Alessandro Rambaldi to Acute Disease
This is a "connection" page, showing publications Alessandro Rambaldi has written about Acute Disease.
Connection Strength
0.198
-
Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19. Leukemia. 2021 09; 35(9):2710-2714.
Score: 0.089
-
Mutations and chromosomal rearrangements of JAK2: not only a myeloid issue. Expert Rev Hematol. 2013 Aug; 6(4):429-39.
Score: 0.052
-
Risk factors associated with development and mortality by invasive fungal diseases in pediatric allogeneic stem cell transplantation. A pediatric subgroup analysis of data from a prospective study of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Bone Marrow Transplant. 2018 09; 53(9):1193-1197.
Score: 0.018
-
Access to alternative donor hematopoietic search and transplantation for acute leukemia in different macro-regions of Italy. A GITMO/IBMDR study. Bone Marrow Transplant. 2018 03; 53(3):291-299.
Score: 0.018
-
Validation of the acute leukemia-EBMT score for prediction of mortality following allogeneic stem cell transplantation in a multi-center GITMO cohort. Am J Hematol. 2017 May; 92(5):429-434.
Score: 0.017
-
Differential response of human acute myeloid leukemia cells to gemtuzumab ozogamicin in vitro: role of Chk1 and Chk2 phosphorylation and caspase 3. Blood. 2003 Jun 01; 101(11):4589-97.
Score: 0.006